Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday, 15 August 2016

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Di Yu, Eric Morand, et al. published in Nature Medicine.

Read article here.

No comments:

Post a Comment